Cargando…

Are the new SARS-CoV-2 variants resistant against the vaccine?

Detalles Bibliográficos
Autores principales:	Abdalla, Mohnad, El-Arabey, Amr Ahmed, Jiang, Xinyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171010/ https://www.ncbi.nlm.nih.gov/pubmed/34047679 http://dx.doi.org/10.1080/21645515.2021.1925503

Ejemplares similares

Transplacental transmission of SARS-CoV-2 infection via NRP1
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2021)

Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties
por: Abdalla, Mohnad, et al.
Publicado: (2022)

New Insight of OCT2 Regulation as Mediator for Cisplatin- Induced Nephrotoxicity
por: EL-Arabey, Amr Ahmed, et al.
Publicado: (2017)

Neuropilin-1 may be responsible for retinal findings in patients with COVID-19
por: El‑Arabey, Amr Ahmed, et al.
Publicado: (2021)

Metformin: Ongoing Journey with Superdrug Revolution
por: EL-Arabey, Amr Ahmed, et al.
Publicado: (2019)

Molecular dynamic and bioinformatic studies of metformin-induced ACE2 phosphorylation in the presence of different SARS-CoV-2 S protein mutations
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2023)

Cardiovascular complications in the post-acute COVID-19 syndrome: A novel perspective down the road
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2022)

Negative Response of Phytoestrogens of Pomegranate Flower Extract against Cisplatin-induced Nephrotoxicity in Female Rats
por: El-Arabey, Amr Ahmed
Publicado: (2016)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model
por: EL-Arabey, Amr Ahmed
Publicado: (2015)

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
por: Tai, Wanbo, et al.
Publicado: (2022)

Metformin as a promising target for DPP4 expression: computational modeling and experimental validation
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2023)

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies
por: Rabie, Amgad M., et al.
Publicado: (2022)

Chronic spontaneous urticaria following vaccination against SARS-CoV-2()
por: Zaiem, Ahmed, et al.
Publicado: (2022)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus
por: Rabie, Amgad M., et al.
Publicado: (2023)

Comment on: Effect of Pomegranate Flower Extract on Cisplatin-induced Nephrotoxicity in Male Rats
por: El-Arabey, Amr Ahmed
Publicado: (2016)

Comment on: Pomegranate Flower Extract Does Not Prevent Cisplatin-induced Nephrotoxicity in Female Rats
por: EL-Arabey, Amr Ahmed
Publicado: (2015)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2
por: Rashid, Haroon ur, et al.
Publicado: (2022)

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
por: Li, Xiao-Feng, et al.
Publicado: (2022)

Correlation of vaccine‐elicited antibody levels and neutralizing activities against SARS‐CoV‐2 and its variants
por: Liu, Jinbiao, et al.
Publicado: (2021)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
por: Tu, Bin, et al.
Publicado: (2022)

New insight for metformin against bladder cancer
por: EL-Arabey, Amr Ahmed
Publicado: (2017)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Correction to: New insight for metformin against bladder cancer
por: EL-Arabey, Amr Ahmed
Publicado: (2018)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

The threat of the spread of SARS-CoV-2 variants in animals
por: Bonilla-Aldana, D. Katterine, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
por: Harder, Thomas, et al.
Publicado: (2021)

Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4fpi9m40mqf5sv9nl4970i5rtp